AXA S.A. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 362 filers reported holding NOVOCURE LTD in Q2 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
AXA S.A. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2022$1,431,572
-15.3%
20,592
+0.9%
0.00%
+50.0%
Q1 2022$1,690,070
+164.5%
20,400
+270.9%
0.00%0.0%
Q3 2021$639,000
-73.8%
5,500
-50.0%
0.00%
-50.0%
Q2 2021$2,440,000
+9.9%
11,000
-34.5%
0.00%
-42.9%
Q1 2021$2,221,000
-80.1%
16,800
-74.0%
0.01%
-80.0%
Q4 2020$11,178,000
+144.9%
64,600
+57.6%
0.04%
+118.8%
Q3 2020$4,564,000
+317.9%
41,000
+122.8%
0.02%
+700.0%
Q2 2020$1,092,000
-70.5%
18,400
-66.5%
0.00%
-77.8%
Q1 2020$3,704,000
-60.4%
55,000
-50.5%
0.01%
-52.6%
Q4 2019$9,354,000
-19.3%
111,000
-28.4%
0.02%
-17.4%
Q3 2019$11,590,000
+45.9%
155,000
+23.4%
0.02%
+43.8%
Q2 2019$7,942,000
+144.7%
125,600
+86.4%
0.02%
+23.1%
Q1 2019$3,246,000
+108.9%
67,400
+45.3%
0.01%
+85.7%
Q4 2018$1,554,000
+86.6%
46,400
+191.8%
0.01%
+133.3%
Q3 2018$833,000
+8.2%
15,900
-35.4%
0.00%0.0%
Q2 2018$770,000
+43.7%
24,6000.0%0.00%
+50.0%
Q1 2018$536,00024,6000.00%
Other shareholders
NOVOCURE LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders